Korea United Pharm’s Sejong‑1 plant, located in Jeon‑dong‑myeon, Sejong Special Self‑Governning City, successfully passed an on‑site inspection by Ukraine’s pharmaceutical regulatory authority, confirming continued compliance with Good Manufacturing Practice (GMP) standards.
The facility originally received GMP approval from Ukrainian authorities in 2023, and the re‑inspection conducted in 2024 also resulted in a favorable assessment. Ukraine conducts GMP reviews using EU guidelines, according to the company.
The company also referenced a 2013 collaboration with multinational pharmaceutical firm TEVA, though details were not expanded in the source.
法规动态2026年9月14日•3 分钟阅读
Korea United Pharm’s Sejong Plant Retains GMP Certification after Ukrainian Inspection
Korea United Pharm announced that its Sejong‑1 plant passed a re‑inspection by Ukraine’s drug regulator, maintaining its GMP certification.
由 Pharmacountry 团队整理 · 来源： KPA News
主题：
评分
(0)
(0)
(0)
(0)
(0)
留下您的评分